⌘K

Home/Filings/4/0001854270-25-000032

4//SEC Filing

Schulz Fran 4

Accession 0001854270-25-000032

CIK 0001854270other

View on SEC.gov Company Profile

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 4:21 PM ET

Size

5.6 KB

Accession

0001854270-25-000032

Insider Transaction Report

Form 4

Period: 2025-03-07

Senti Biosciences, Inc.SNTI

Director

Transactions

Award
Stock Option (Right to Buy)
2025-03-07+43,900→ 43,900 total
Exercise: $3.52Exp: 2035-03-06→ Common Stock (43,900 underlying)

Footnotes (1)

[F1]100% of the shares underlying this option vest on the first anniversary of the date of grant, subject to the reporting person's continued service through the applicable vesting date.

Documents

1 file

4
wk-form4_1741724456.xmlPrimary
FORM 4

Issuer

Senti Biosciences, Inc.

CIK 0001854270

Entity typeother

Related Parties

1

filerCIK 0002046804

Filing Metadata

Form type: 4
Filed: Mar 10, 8:00 PM ET
Accepted: Mar 11, 4:21 PM ET
Size: 5.6 KB

View on SEC.gov